Shenlian Biomedical (688098.SH) approved for new animal drug registration.

Zhtng Cijng APP News, Shenlian Biology (688098.SH) announced that, according to the "Regulations on Veterinary Drugs Management" and "Procedures for Veterinary Drug Registration", the avian adenovirus (Group , Type 4) inactivated vaccine (DN strain) jointly developed by the company and other units has been approved as a new veterinary drug after review by the Ministry of Agriculture and Rural Affairs of the People's Republic of China, and the "Certificate of New Veterinary Drug Registration" has been issued.